Guided Therapeutics (GTHP) Short term Debt (2011 - 2024)
Guided Therapeutics (GTHP) reported Short term Debt of $1.1 million for Q3 2024, little changed sequentially from $1.1 million in Q2 2024.
Guided Therapeutics (GTHP) Short term Debt (2011 - 2024) Analysis & Trends
Guided Therapeutics (GTHP) has 13 years of Short term Debt data on file, last reported at $1.1 million in Q3 2024.
- For the quarter ending Q3 2024, Short term Debt changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2024 stood at $1.1 million (changed N/A YoY), and the FY2022 full-year result was $17000.0, down 80.68% from the prior year.
- Short term Debt steadied at $1.1 million in Q3 2024, from $1.1 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.1 million in Q2 2024 to a low of $17000.0 in Q4 2022.
- A 4-year average of $330454.5 and a median of $88000.0 in 2021 frame the typical range for Short term Debt.
- Peak annual rise in Short term Debt reached 2661.11% in 2022, while the deepest fall reached 84.74% in 2022.
- Tracing GTHP's Short term Debt over 4 years: stood at $328000.0 in 2020, then slumped by 73.17% to $88000.0 in 2021, then plunged by 80.68% to $17000.0 in 2022, then surged by 6547.06% to $1.1 million in 2024.
- Business Quant data shows GTHP's Short term Debt at $1.1 million in Q3 2024, $1.1 million in Q2 2024, and $17000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.13 Mn |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 497,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 18,000.00 |
| Jun 30, 2021 | 308,000.00 |
| Mar 31, 2021 | 45,000.00 |
| Dec 31, 2020 | 328,000.00 |
| Sep 30, 2019 | 97,000.00 |
| Mar 31, 2019 | 445,000.00 |
| Sep 30, 2018 | 1.03 Mn |
| Jun 30, 2018 | 973,000.00 |
| Mar 31, 2018 | 905,000.00 |
| Dec 31, 2017 | 1.09 Mn |
| Sep 30, 2017 | 814,000.00 |
| Jun 30, 2017 | 585,000.00 |
| Mar 31, 2017 | 595,000.00 |